A new clinical trial will study whether the active ingredient in Latisse—bimatoprost—could be used as a hair growth treatment for baldness. Latisse is currently the only FDA-approved prescription product that stimulates the growth of eyelashes.
The first phase of the trials will have about 28 patients: men with moderate male-pattern baldness and women with moderate female-pattern hair loss. Some doctors have already been using Latisse as an off-label treatment for hair loss.
Hair-restoration expert Dr. Alan Bauman, who reports modest hair growth for his patients that have used it, believes that “Allergan [the maker of Latisse] will likely test a stronger concentration for the use on the scalp than the 0.03% bimatoprost found in Latisse.”
For use on eyelashes, clinical studies demonstrated that 78 percent of patients reported significant eyelash enhancement. On average, participants had lashes that were 25 percent longer, 18 percent darker and over 100 percent fuller.
Results from using Latisse generally begin to appear after about four weeks, but they are not permanent, so patients must continue to use the product to maintain results.
Interested in trying Latisse? Allergan is currently offering a free trial certificate for Latisse for those who donate a minimum of $20 to the Make-A-Wish Foundation. Besides the free trial, Allergan will double your donation.